| Literature DB >> 35228586 |
Chrysoula Vraka1, Matej Murgaš2, Lucas Rischka2, Barbara Katharina Geist1, Rupert Lanzenberger2, Gregor Gryglewski2, Thomas Zenz1, Wolfgang Wadsak1,3, Markus Mitterhauser1,4, Marcus Hacker1, Cécile Philippe5, Verena Pichler6.
Abstract
Simultaneous characterization of pathologies by multi-tracer positron emission tomography (PET) is among the most promising applications in nuclear medicine. Aim of this work was the simultaneous production of two PET-tracers in one module and test the relevance for human application. [11C]harmine and [11C]DASB were concurrently synthesized in a 'two-in-one-pot' reaction in quality for application. Dual-tracer protocol was simulated using 16 single PET scans in different orders of tracer application separated by different time intervals. Volume of distribution was calculated for single- and dual-tracer measurements using Logan's plot and arterial input function in 13 brain regions. The 'two-in-one-pot' reaction yielded equivalent amounts of both radiotracers with comparable molar activities. The simulations of the dual-tracer application were comparable to the single bolus injections in 13 brain regions, when [11C]harmine was applied first and [11C]DASB second, with an injection time interval of 45 min (rxy = 0.90). Our study shows the successful simultaneous dual-tracer production leading to decreased radiation burden and costs. The simulation of dual subject injection to quantify the monoamine oxidase-A and serotonin transporter distribution proved its high potential. Multi-tracer imaging may drive more sophisticated study designs and diminish the day-to-day differences in the same individual as well as increase PET scanner efficiency.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35228586 PMCID: PMC8885643 DOI: 10.1038/s41598-022-06906-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379